(202) 599-8435

DEA Opioid Cuts Could Affect Terminally Ill Patients

dea-logoThe Drug Enforcement Administration is reducing production quotas for nearly every Schedule II opioid pain medication by 25 percent or more. While some argue that this is a step in the right direction for those suffering from substance use disorder, those treating patients that are terminally or chronically ill believe the reduction may lead to shortages. Read more here.

Print Friendly
About the Author